Antibodies
-
{
- All
- News
- Videos
- Web Stories
-
WHO Fast-Tracks Vaccines, Drugs Against Deadly Ebola Bundibugyo Strain
The Bundibugyo strain is one of several types of Ebola viruses known to infect humans. While Ebola is linked to severe bleeding, organ failure, and high death rates, different strains can behave differently.
-
Can Antibodies From Camels Help Develop Dengue Vaccines? Researchers From Mohali Reveal
Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies from camels may help neutralise the dengue virus. Scientists say these tiny "nanobodies" could pave the way for future dengue tr
-
Your Age May Influence Antibody Production In Response To A Virus: Study
Age strongly influences antibody production against viruses, researchers find. A Nature Immunology study shows age, sex, and genetics shape immune responses, with implications for tailored treatments.
-
India Develops New Antibody Discovery Platform To Transform Diagnostics
A team of researchers at the Indian Institute of Technology (IIT) Roorkee on Tuesday announced the development of a next-generation antibody discovery platform that has the potential to transform diagnostics and therapeutics.
-
Medical Breakthrough: Study Finds New Treatment Effective For Rare Liver Disease
A new monoclonal antibody treatment has shown promising results for a rare liver disease called primary sclerosing cholangitis (PSC).
-
What Happens When Leukemia Relapses: Highlighting The Role Of Bispecific Antibodies
Relapse in leukemia is challenging, but treatments like bispecific antibodies are changing the game.
-
MIT’s CuRVE Technique Achieves Uniform Protein Labeling in Intact Tissues
A breakthrough in protein labeling has been introduced by MIT scientists, addressing challenges in studying intact tissues. Their method, CuRVE, allows antibodies to evenly distribute without damaging structure. The approach, combined with stochastic electrotransport, ensures rapid and uniform protein tagging. Tests on various tissues, including mo...
-
New UCLA Therapy Shows Promise in Preventing Heart Failure After Heart Attacks
UCLA’s Broad Center researchers have developed an antibody therapy to help the heart heal after a heart attack. This therapy, which blocks the ENPP1 protein, reduces scar tissue formation that can lead to heart failure. Early tests showed that treated animals had less scarring and a reduced risk of severe heart failure. With plans for human trial...
-
Antibody That Can Counter All Known Covid Variants Found
Researchers have discovered an antibody that could counter all known variants of the coronavirus that causes COVID-19 and also distantly related ones that infect other animals.
-
New HIV Vaccine Candidate Shows Promise In Early Trials
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
-
New Asthma Treatment Offers Hope With Reduced Steroid Dependence
Research indicates that severe asthma can be managed effectively through biologic therapies, eliminating the need for additional high-dose inhaled steroids with potential significant side effects.
-
Monoclonal Antibody, Only Treatment Against Nipah Infection, Reaches Kerala
The monoclonal antibody required to treat the Nipah virus infection has arrived in the state, Kerala said today.
-
Quality Of Antibodies Improves For Months After Covid Vaccination: Study
Antibodies produced by immune cells become steadily more formidable and precisely targeted against the SARS-CoV-2 virus for at least six months after COVID-19 vaccination, according to a study.
-
Exercising After Getting Covid Vaccine Boosts Antibodies: Study
Mild- to moderate-intensity exercise for 90 minutes after getting a flu or COVID-19 vaccine may boost the levels of antibodies in the body, according to a study.
-
Patients With High Covid Risk Least Likely To Get Monoclonal Antibodies: Study
According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.
-
WHO Fast-Tracks Vaccines, Drugs Against Deadly Ebola Bundibugyo Strain
The Bundibugyo strain is one of several types of Ebola viruses known to infect humans. While Ebola is linked to severe bleeding, organ failure, and high death rates, different strains can behave differently.
-
Can Antibodies From Camels Help Develop Dengue Vaccines? Researchers From Mohali Reveal
Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies from camels may help neutralise the dengue virus. Scientists say these tiny "nanobodies" could pave the way for future dengue tr
-
Your Age May Influence Antibody Production In Response To A Virus: Study
Age strongly influences antibody production against viruses, researchers find. A Nature Immunology study shows age, sex, and genetics shape immune responses, with implications for tailored treatments.
-
India Develops New Antibody Discovery Platform To Transform Diagnostics
A team of researchers at the Indian Institute of Technology (IIT) Roorkee on Tuesday announced the development of a next-generation antibody discovery platform that has the potential to transform diagnostics and therapeutics.
-
Medical Breakthrough: Study Finds New Treatment Effective For Rare Liver Disease
A new monoclonal antibody treatment has shown promising results for a rare liver disease called primary sclerosing cholangitis (PSC).
-
What Happens When Leukemia Relapses: Highlighting The Role Of Bispecific Antibodies
Relapse in leukemia is challenging, but treatments like bispecific antibodies are changing the game.
-
MIT’s CuRVE Technique Achieves Uniform Protein Labeling in Intact Tissues
A breakthrough in protein labeling has been introduced by MIT scientists, addressing challenges in studying intact tissues. Their method, CuRVE, allows antibodies to evenly distribute without damaging structure. The approach, combined with stochastic electrotransport, ensures rapid and uniform protein tagging. Tests on various tissues, including mo...
-
New UCLA Therapy Shows Promise in Preventing Heart Failure After Heart Attacks
UCLA’s Broad Center researchers have developed an antibody therapy to help the heart heal after a heart attack. This therapy, which blocks the ENPP1 protein, reduces scar tissue formation that can lead to heart failure. Early tests showed that treated animals had less scarring and a reduced risk of severe heart failure. With plans for human trial...
-
Antibody That Can Counter All Known Covid Variants Found
Researchers have discovered an antibody that could counter all known variants of the coronavirus that causes COVID-19 and also distantly related ones that infect other animals.
-
New HIV Vaccine Candidate Shows Promise In Early Trials
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
-
New Asthma Treatment Offers Hope With Reduced Steroid Dependence
Research indicates that severe asthma can be managed effectively through biologic therapies, eliminating the need for additional high-dose inhaled steroids with potential significant side effects.
-
Monoclonal Antibody, Only Treatment Against Nipah Infection, Reaches Kerala
The monoclonal antibody required to treat the Nipah virus infection has arrived in the state, Kerala said today.
-
Quality Of Antibodies Improves For Months After Covid Vaccination: Study
Antibodies produced by immune cells become steadily more formidable and precisely targeted against the SARS-CoV-2 virus for at least six months after COVID-19 vaccination, according to a study.
-
Exercising After Getting Covid Vaccine Boosts Antibodies: Study
Mild- to moderate-intensity exercise for 90 minutes after getting a flu or COVID-19 vaccine may boost the levels of antibodies in the body, according to a study.
-
Patients With High Covid Risk Least Likely To Get Monoclonal Antibodies: Study
According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.
